DDI Publications List

Maclean EC, Mohammad A, Khatoon N, Abraham S, Carballo M. Perceptions of body size among a multi-ethnic population in Kuwait. Intl J Nurs, 2017; 1-6.

Holman RR, Coleman RL, Chan JCN, Chiasson JL, Feng H, Ge J, Gerstein HC, Gray R, Huo Y, Lang Z, McMurray JJ,…Tuomilehto J, et al. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017;5(11):877-886.

Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K,…Tuomilehto, J, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017; pii: S0140-6736(17)32409-1.

Miettinen ME, Smart MC, Kinnunen L, Harjutsalo V, Reinert-Hartwall L, Ylivinkka I, Surcel HM, Lamberg-Allardt C, Hitman GA, Tuomilehto J. Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child. PLoS One. 2017;12(10):e0184942

Kraja AT, Cook JP, Warren HR, Surendran P, Liu C, Evangelou E, Manning AK, Grarup N, Drenos F, Sim X,…Tuomilehto J, et al. New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals. Circ Cardiovasc Genet. 2017;10(5).

Hassanein M, Echtay A, Hassoun A, Alarouj M, Afandi B, Poladian R, et al. Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS). Int J Clin Pract. 2017;71(10).

Wheeler, E, Leong, A, Liu, CT, Hivert, MF, Strawbridge, RJ, Podmore, C, Li, M, Yao, J, Sim, X, Hong, J…Tuomilehto, J, et al. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med. 2017;14(9):e1002383.

Walle P, Takkunen M, Mannisto V, Vaittinen M, Kakela P, Agren J, Schwab U, Lindstrom J, Tuomilehto J, Uusitupa M, Pihlajamaki J. Alterations in fatty acid metabolism in response to obesity surgery combined with dietary counseling. Nutr Diabetes. 2017;7(9):e285.

Kulkarni M, Foraker RE, McNeill AM, Girman C, Golden SH, Rosamond WD Duncan B, Schmidt MI, Tuomilehto J. Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants. Diabetes Obes Metab. 2017;19(9):1260-6.

Wood AR, Jonsson A, Jackson AU, Wang N, Leewen NV, Palmer ND, Kobes S, Deelen J, Boquete-Vilarino L, Paananen J ...Tuomilehto J, et al. A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants. Diabetes. 2017;66(8):2296-309.

Carballo M, Khatoon N, Maclean EC, Al-Hamad N, Mohammad A, Al-Wotayan R, Abraham S. Infant and young child feeding patterns in Kuwait: results of a cross-sectional survey. Public Health Nutr. 2017;20(12):2201-7.

Alkhatib A, Atcheson R. Yerba Mate (Ilex paraguariensis) Metabolic, Satiety, and Mood State Effects at Rest and during Prolonged Exercise. Nutrients. 2017;9(8).

Wain LV, Vaez A, Jansen R, Joehanes R, van der Most PJ, Erzurumluoglu AM, O'Reilly PF, Cabrera CP, Warren HR, Rose LM ...Tuomilehto J, et al. Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney. Hypertension. 2017; 117.09438.

Stephen R, Liu Y, Ngandu T, Rinne JO, Kemppainen N, Parkkola R, Laatikainen T, Paajanen T, Hanninen T, Strandberg T...Tuomilehto J, et al. Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition. J Alzheimers Dis. 2017;59(2):695-705.

Manning A, Highland HM, Gasser J, Sim X, Tukiainen T, Fontanillas P, Grarup N, Rivas MA, Mahajan A ...Tuomilehto J, et al. A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. Diabetes. 2017;66(7):2019-32.

Lee CMY, Woodward M, Pandeya N, Adams R, Barrett-Connor E, Boyko EJ, Eliasson M, Franco LJ, Fujimoto WY, Gonzalez C ...Tuomilehto J, et al. Comparison of relationships between four common anthropometric measures and incident diabetes. Diabetes Res Clin Pract. 2017;132:36-44.

Abu-Farha M, Abubaker J, Tuomilehto J. ANGPTL8 (betatrophin) role in diabetes and metabolic diseases. Diabetes Metab Res Rev. 2017;33(8).

Mall R, Rawi R, Ullah E, Kunji K, Khadir A, Tiss A, Abubaker J, Kulinski MA, Ramzi MM, Dehbi M, Bensmail H. Application of High-Dimensional Statistics and Network Based Visualization Techniques on Arab Diabetes and Obesity Data. J Health Med Informat, 2017; 8:2.

John SE, Antony D, Eaaswarkhanth M, Hebbar P, Alkayal F, Tuomilehto J, Alsmadi O, Thanaraj TA. Genetic variants associated with warfarin dosage in Kuwaiti population. Pharmacogenomics. 2017;18(8):757-64.

Al-Mulla F. Vesicular control of metastasis: entrap the “virtuous” and free the “wicked” microRNA. Transl Cancer Res. 2017; 6(S6):S999-S1002.